Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxazosin 3mg/5ml oral liquid
0205040D0AAAPAP
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 4mg capsules
0205040D0AAAFAF
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 500micrograms/5ml oral liquid
0205040D0AAAUAU
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 5mg/5ml oral liquid
0205040D0AAAKAK
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 6mg/5ml oral liquid
0205040D0AAASAS
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 80mg/5ml oral liquid
0205040D0AAAVAV
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 8mg/5ml oral liquid
0205040D0AAAHAH
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxzogen XL 4mg tablets
0205040D0BIAAAQ
|
Doxzogen | Doxazosin mesilate | Cardiovascular System | No data available |
|
Dried Factor VIII Fraction type 8Y 250unit inj vials
0211000I0BHAAAA
|
Dried Factor VIII Fraction Type 8Y | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Dried Factor VIII Fraction type 8Y 500unit inj vials
0211000I0BHABAV
|
Dried Factor VIII Fraction Type 8Y | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Drotrecogin alfa 20mg powder for solution for infusion vials
0211000V0AAABAB
|
Drotrecogin alfa | Drotrecogin alfa | Cardiovascular System | No data available |
|
Drotrecogin alfa 5mg powder for solution for infusion vials
0211000V0AAAAAA
|
Drotrecogin alfa | Drotrecogin alfa | Cardiovascular System | No data available |
|
Dupromex 10mg tablets
0204000R0BWAAAH
|
Dupromex | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Dyazide 50mg/25mg tablets
0202040H0BBAAAA
|
Dyazide | Co-triamterzide(Triamterene/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Dynamin 10mg tablets
0206010K0BUAAAB
|
Dynamin | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Dynamin 20mg tablets
0206010K0BUABAC
|
Dynamin | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Dynamin XL25 capsules
0206010K0BUACAH
|
Dynamin | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Dynamin XL50 capsules
0206010K0BUADAF
|
Dynamin | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Dytac 50mg capsules
0202030W0BBAAAA
|
Dytac | Triamterene | Cardiovascular System | No data available |
|
Dytide capsules
0202040V0BDAAAC
|
Dytide | Triamterene with thiazides | Cardiovascular System | No data available |
|
Ecopace 12.5mg tablets
0205051F0BDAAAD
|
Ecopace | Captopril | Cardiovascular System | No data available |
|
Ecopace 25mg tablets
0205051F0BDABAE
|
Ecopace | Captopril | Cardiovascular System | No data available |
|
Ecopace 50mg tablets
0205051F0BDACAF
|
Ecopace | Captopril | Cardiovascular System | No data available |
|
Effortil 5mg tablets
0207010G0BBAAAA
|
Effortil | Etilefrine hydrochloride | Cardiovascular System | No data available |
|
Eicosapent acid 170mg/Docosahexaenoic acid 115mg/g oral liq
0212000V0AAAAAA
|
EPA/DHA | Omega-3 marine triglycerides | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.